Benjamin E. Blass
32Patents
5h-index
39Co-inventors
69Inventor score
Filing activity: Nov 8, 2001 → Sep 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6727364B2 | Triazole compounds useful in treating diseases associated with unwanted cytokine activity | Chemistry; Metallurgy | 24 | Expired |
| US6787555B2 | Triazole compounds useful in treating diseases associated with unwanted cytokine activity | Chemistry; Metallurgy | 22 | Expired |
| US9725427B2 | Prodrugs of riluzole and their method of use | Chemistry; Metallurgy | 15 | Active |
| US9802924B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 6 | Active |
| US10858368B2 | Modulators of the 5-hydroxytryptamine receptor 7 and their method of use | Chemistry; Metallurgy | 5 | Active |
| US11319327B2 | Modulators of the 5-hydroxytryptamine receptor 7 and their method of use | Chemistry; Metallurgy | 4 | Active |
| US10131637B2 | Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases | Chemistry; Metallurgy | 4 | Active |
| US10287274B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 3 | Active |
| US9464062B2 | Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators | Chemistry; Metallurgy | 3 | Active |
| US10676464B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 3 | Active |
| US10961249B2 | Modulators of the sigma-2 receptor and their method of use | Chemistry; Metallurgy | 3 | Active |
| US10544117B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 3 | Active |
| US10239868B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 3 | Active |
| US11220505B2 | 5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents | Human Necessities | 2 | Active |
| US10562870B2 | Prodrugs of riluzole and their method of use | Chemistry; Metallurgy | 2 | Active |
| US11440893B2 | Prodrugs of riluzole and their method of use | Chemistry; Metallurgy | 1 | Active |
| US11897870B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 1 | Active |
| US6635769B1 | Process for making functionalized oxazolidinone compounds | Chemistry; Metallurgy | 1 | Expired |
| US11192871B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 1 | Active |
| US9975879B2 | Beta lactams as modulators of glutamate uptake and methods for use thereof | Chemistry; Metallurgy | 1 | Active |
| US10844026B2 | Prodrugs of riluzole and their method of use | Chemistry; Metallurgy | 1 | Active |
| US11807642B2 | 5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents | Human Necessities | 1 | Active |
| US12269809B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Chemistry; Metallurgy | 0 | Active |
| US12338247B2 | Modulators of the 5-hydroxytryptamine receptor 7 and their method of use | Chemistry; Metallurgy | 0 | Active |
| US7803827B2 | Kv1.5 potassium channel inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.